Download Leukaemia Section t(17;21)(q11.2;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Rh blood group system wikipedia , lookup

Complement component 4 wikipedia , lookup

Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Leukaemia Section
Short Communication
t(17;21)(q11.2;q22)
Jean-Loup Huret
Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
(JLH)
Published in Atlas Database: February 2000
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t1721ID1181.html
DOI: 10.4267/2042/37597
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2000 Atlas of Genetics and Cytogenetics in Oncology and Haematology
Protein
Contains a Runt domain and, in the C-term, a
transactivation domain; forms heterodimers; widely
expressed; nuclear localisation; transcription factor
(activator) for various hematopoietic-specific genes.
Clinics and pathology
Disease
Acute non lymphoblastic leukemia (ANLL) and
myelodysplastic syndromes (MDS); de novo ANLL
and treatment related leukemias (t-ANLL).
Result of the chromosomal
anomaly
Phenotype/cell stem origin
One M2, one treatment related RAEBt/M4, one tANLL.
Hybrid gene
Etiology
Description
5 prime AML1-3 prime unknown; breakpoint in intron
5 or 6 of AML1.
Two cases are secondary to treatment with
topoisomerase II inhibitors for Hodgkin disease and
neuroblastoma.
Fusion protein
Epidemiology
Description
The N-term is provided by AML1, as in the t(3;21) and
in the t(8;21) associated with ANLLs, whereas, in the
ALL with t(12;21), the fusion protein comprises the Cterm part of AML1.
3 cases to date; 1M/2F, aged 2yrs, 39 yrs and 76 yrs.
Prognosis
Unknown.
Cytogenetics
References
Additional anomalies
Sole anomaly in one case; one case was also -7, +8, one
case showed also a t(11;12)(p15;q13) with NUP98
rearrangement.
Roulston D, Espinosa R 3rd, Nucifora G, Larson RA, Le Beau
MM, Rowley JD. CBFA2(AML1) translocations with novel
partner chromosomes in myeloid leukemias: association with
prior therapy. Blood. 1998 Oct 15;92(8):2879-85
Genes involved and proteins
Kobzev YN, Rowley JD. NUP98 gene rearrangements in
leukemia detected by fluorescence in situ hybridization (FISH).
Blood. 1999 ; 94 (numero Suppl 1).
Note
The gene involved in 17q11 is unknown; the breakpoint
on chromosome 17 is between the loci for NF1 and
RARA.
LySunnaram B, Gandemer V, Le Mee F, Cayuela JM, Edan C,
Le Gall E, Goasguen JE. Secondary raeb-t associated with
t(17;21) in a child treated by VP16 for neuroblastoma. Blood.
1999 ; 94 (numero Suppl 1).
AML1
This article should be referenced as such:
Location
21q22
DNA/RNA
Transcription is from telomere to centromere.
Atlas Genet Cytogenet Oncol Haematol. 2000; 4(1)
Huret JL. t(17;21)(q11.2;q22). Atlas Genet Cytogenet Oncol
Haematol. 2000; 4(1):37.
37
Related documents
Leukaemia Section t(1;21)(p36;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p36;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(20;21)(q13;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(20;21)(q13;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(2;21)(p11;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;21)(q24;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;21)(q24;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(4;21)(q31;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(4;21)(q31;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(14;21)(q22;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(14;21)(q22;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(15;21)(q22;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(15;21)(q22;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(19;21)(q13.4;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(19;21)(q13.4;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(18;21)(q21;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Genes Section DDX10 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 10) Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;5)(q25;q34) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Gene Section ABI1 (Abl-Interactor 1) Atlas of Genetics and Cytogenetics
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(5;17)(q33;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section ETO (eigth twenty one) Atlas of Genetics and Cytogenetics
Gene Section ETO (eigth twenty one) Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;21)(q26;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;21)(q26;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(X;21)(p22;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(X;21)(p22;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;21)(p12;q22)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(12;21)(p12;q22) Atlas of Genetics and Cytogenetics
Leukaemia Section t(1;21)(p32;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(1;21)(p32;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;22)(p13;q11-12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(12;22)(p13;q11-12) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(8;21)(q22;q22)  Atlas of Genetics and Cytogenetics
Leukaemia Section t(8;21)(q22;q22) Atlas of Genetics and Cytogenetics
Leukaemia Section inv(16)(p13q22) in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section inv(16)(p13q22) in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section 21q22 rearrangements in
Leukaemia Section 21q22 rearrangements in